These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2309246)

  • 1. Relative distribution of 2,3,7,8-tetrachlorodibenzo-p-dioxin in human hepatic and adipose tissues.
    Leung HW; Wendling JM; Orth R; Hileman F; Paustenbach DJ
    Toxicol Lett; 1990 Feb; 50(2-3):275-82. PubMed ID: 2309246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. 1. Dose-dependent tissue distribution and induction of hepatic ethoxyresorufin O-deethylase in rats following a single injection.
    Abraham K; Krowke R; Neubert D
    Arch Toxicol; 1988; 62(5):359-68. PubMed ID: 3242446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue distribution after a single subcutaneous administration of 2,3,7,8-tetrabromodibenzo-p-dioxin in comparison with toxicokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Wistar rats.
    Nagao T; Yamashita K; Golor G; Bittmann H; Körner W; Hagenmaier H; Neubert D
    Life Sci; 1996; 58(4):325-36. PubMed ID: 8538369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of [125I]-2-iodo-3,7,8-trichlorodibenzo-p-dioxin in mice: analysis with a physiological modeling approach.
    Leung HW; Poland A; Paustenbach DJ; Murray FJ; Andersen ME
    Toxicol Appl Pharmacol; 1990 May; 103(3):411-9. PubMed ID: 2339414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative dermal absorption of 2,3,7,8-tetrachlorodibenzo-p-dioxin and three polychlorinated dibenzofurans.
    Brewster DW; Banks YB; Clark AM; Birnbaum LS
    Toxicol Appl Pharmacol; 1989 Jan; 97(1):156-66. PubMed ID: 2916232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The toxicological significance of 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds in human adipose tissue.
    Byard JL
    J Toxicol Environ Health; 1987; 22(4):381-403. PubMed ID: 3694702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of 2,3,7,8-tetrabromodibenzo-p-dioxin and 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat: biliary excretion and induction of cytochromes CYP1A1 and CYP1A2.
    Kedderis LB; Diliberto JJ; Linko P; Goldstein JA; Birnbaum LS
    Toxicol Appl Pharmacol; 1991 Oct; 111(1):163-72. PubMed ID: 1949032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A physiological pharmacokinetic description of the tissue distribution and enzyme-inducing properties of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat.
    Leung HW; Paustenbach DJ; Murray FJ; Andersen ME
    Toxicol Appl Pharmacol; 1990 May; 103(3):399-410. PubMed ID: 2160135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. 2. Pharmacokinetics in rats using a loading-dose/maintenance-dose regime with high doses.
    Krowke R; Chahoud I; Baumann-Wilschke I; Neubert D
    Arch Toxicol; 1989; 63(5):356-60. PubMed ID: 2818199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a physiologically based pharmacokinetic model for rats to study the influence of body fat mass and induction of CYP1A2 on the pharmacokinetics of TCDD.
    Emond C; Birnbaum LS; DeVito MJ
    Environ Health Perspect; 2006 Sep; 114(9):1394-400. PubMed ID: 16966094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicokinetics of dioxins and other organochlorine compounds in Japanese people: association with hepatic CYP1A2 expression levels.
    Watanabe MX; Kunisue T; Ueda N; Nose M; Tanabe S; Iwata H
    Environ Int; 2013 Mar; 53():53-61. PubMed ID: 23333656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated in utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure affects male gonads in offspring, leading to sex ratio changes in F2 progeny.
    Ikeda M; Tamura M; Yamashita J; Suzuki C; Tomita T
    Toxicol Appl Pharmacol; 2005 Aug; 206(3):351-5. PubMed ID: 16039946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacokinetic analysis of interspecies extrapolation in dioxin risk assessment.
    Lawrence GS; Gobas FA
    Chemosphere; 1997 Aug; 35(3):427-52. PubMed ID: 9241819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of dose on 2,3,7,8-TCDD tissue distribution, metabolism and elimination in CYP1A2 (-/-) knockout and C57BL/6N parental strains of mice.
    Hakk H; Diliberto JJ; Birnbaum LS
    Toxicol Appl Pharmacol; 2009 Nov; 241(1):119-26. PubMed ID: 19695277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2,3,7,8-Tetrachlorodibenzo-p-dioxin pretreatment of female mice altered tissue distribution but not hepatic metabolism of a subsequent dose.
    Curtis LR; Kerkvliet NI; Baecher-Steppan L; Carpenter HM
    Fundam Appl Toxicol; 1990 Apr; 14(3):523-31. PubMed ID: 2340981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue disposition of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in maternal and developing long-evans rats following subchronic exposure.
    Hurst CH; DeVito MJ; Birnbaum LS
    Toxicol Sci; 2000 Oct; 57(2):275-83. PubMed ID: 11006357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The distribution of [14C]-2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and its effect on the vitamin A content in parenchymal and stellate cells of rat liver.
    Håkansson H; Hanberg A
    J Nutr; 1989 Apr; 119(4):573-80. PubMed ID: 2703915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response relationships of tissue distribution and induction of CYP1A1 and CYP1A2 enzymatic activities following acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice.
    Diliberto JJ; Akubue PI; Luebke RW; Birnbaum LS
    Toxicol Appl Pharmacol; 1995 Feb; 130(2):197-208. PubMed ID: 7871533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue distribution, metabolism, and excretion of 14C-TCDD in a TCDD-susceptible and a TCDD-resistant rat strain.
    Pohjanvirta R; Vartiainen T; Uusi-Rauva A; Mönkkönen J; Tuomisto J
    Pharmacol Toxicol; 1990 Feb; 66(2):93-100. PubMed ID: 2315270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.